Insights

Expanding Market Presence Rhythm Pharmaceuticals is actively commercializing Imcivree across North America and Europe, with recent partnerships like the exclusive U.S. pharmacy agreement with PANTHERx Rare highlighting their focus on expanding access for rare disease treatments. This indicates ongoing opportunities to collaborate with healthcare providers and pharmacies to broaden distribution channels.

Focus on Rare Diseases The company's strong emphasis on developing therapies for rare neuroendocrine and MC4R pathway diseases positions it as a key provider in niche markets. Businesses offering specialized diagnostic tools, support services, or complementary therapies for these conditions could find strategic partnership opportunities to enhance treatment offerings.

Innovative Product Pipeline Rhythm is advancing a broad clinical program including investigational MC4R agonists and preclinical small molecules, indicating a sustained pipeline of potential new treatments. Companies in biotech supply, research collaborations, or companion diagnostics can explore partnership possibilities with Rhythm to accelerate development and commercialization.

Engagement in Industry Events Participation in top-tier biotech summits and healthcare conferences like the Guggenheim Biotech Summit and Oppenheimer Healthcare Conference suggests Rhythm is open to strategic dialogues. Engaging at these forums can present opportunities for sales, partnerships, or licensing negotiations with decision-makers.

Financial and Market Opportunities With revenue estimates between 50 million and 100 million USD and a workforce focused on innovation, Rhythm presents a promising target for vendors offering support services, technology solutions, or market expansion expertise. Its growth trajectory and focus on rare disease treatment mean sales efforts tailored to biotech commercialization and R&D support can be highly impactful.

Rhythm Pharmaceuticals Inc. Tech Stack

Rhythm Pharmaceuticals Inc. uses 8 technology products and services including SAS/GRAPH, Elastic stack (ELK), Salesforce Health Cloud, and more. Explore Rhythm Pharmaceuticals Inc.'s tech stack below.

  • SAS/GRAPH
    Business Intelligence
  • Elastic stack (ELK)
    Data Management
  • Salesforce Health Cloud
    Electronic Health Records
  • Microsoft Outlook
    Email
  • ADP Workforce Now
    Human Capital Management
  • Amazon CloudWatch
    IT Infrastructure Monitoring
  • Microsoft Windows
    Operating Systems
  • Linux
    Programming Languages

Media & News

Rhythm Pharmaceuticals Inc.'s Email Address Formats

Rhythm Pharmaceuticals Inc. uses at least 1 format(s):
Rhythm Pharmaceuticals Inc. Email FormatsExamplePercentage
FLast@rhythmtx.comJDoe@rhythmtx.com
90%
Last@rhythmtx.comDoe@rhythmtx.com
6%
First-Last@rhythmtx.comJohn-Doe@rhythmtx.com
2%
FMiddleLast@rhythmtx.comJMichaelDoe@rhythmtx.com
2%

Frequently Asked Questions

Where is Rhythm Pharmaceuticals Inc.'s headquarters located?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc.'s main headquarters is located at 222 Berkeley Street 12th Floor Boston, Massachusetts 02116 United States. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Rhythm Pharmaceuticals Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Rhythm Pharmaceuticals Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Rhythm Pharmaceuticals Inc.'s stock symbol?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc. is a publicly traded company; the company's stock symbol is RYTM.

What is Rhythm Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc.'s official website is rhythmtx.com and has social profiles on LinkedInCrunchbase.

What is Rhythm Pharmaceuticals Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Rhythm Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, Rhythm Pharmaceuticals Inc. has approximately 469 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Technical Officer: J. S.Chief Human Resources Officer: P. C.Chief Scientific Officer: A. G.. Explore Rhythm Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does Rhythm Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc. operates in the Biotechnology Research industry.

What technology does Rhythm Pharmaceuticals Inc. use?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc.'s tech stack includes SAS/GRAPHElastic stack (ELK)Salesforce Health CloudMicrosoft OutlookADP Workforce NowAmazon CloudWatchMicrosoft WindowsLinux.

What is Rhythm Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc.'s email format typically follows the pattern of FLast@rhythmtx.com. Find more Rhythm Pharmaceuticals Inc. email formats with LeadIQ.

When was Rhythm Pharmaceuticals Inc. founded?

Minus sign iconPlus sign icon
Rhythm Pharmaceuticals Inc. was founded in 2008.

Rhythm Pharmaceuticals Inc.

Biotechnology ResearchMassachusetts, United States201-500 Employees

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause. 

The Company develops medicines for previously untreatable or undertreated diseases and provides meaningful support for healthcare providers and patients and their families. In addition to commercializing its lead asset in North America, Europe and other regions, Rhythm is advancing a broad clinical development program in rare MC4R pathway diseases, as well as investigational MC4R agonists, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism.

At Rhythm, we know our work makes an important difference in the lives of patients and their families around the world. Every employee contributes to the company’s goal of discovering new treatments for rare diseases that no other company is developing. As a fast-growing company with an exciting future, we offer a collaborative environment where employees’ contributions truly matter, which is one of the many reasons we were recognized as one of The Boston Globe’s Top Places to Work in Massachusetts for 2023 and 2024.

Section iconCompany Overview

Headquarters
222 Berkeley Street 12th Floor Boston, Massachusetts 02116 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RYTM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
201-500

Section iconFunding & Financials

  • $50M$100M

    Rhythm Pharmaceuticals Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Rhythm Pharmaceuticals Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.